Mammary Cancer in Cats: A Comprehensive Guide to Diagnosis and Prognosis

Mammary cancer in cats is a serious health issue that affects many felines worldwide. According to the article, mammary cancer is the most common type of cancer in intact female cats.

The risk of developing mammary cancer increases with age, with most cases occurring in cats over 10 years old. This is a crucial fact to keep in mind, especially for cat owners who have older felines.

Early detection is key to effective treatment and improved prognosis. Regular veterinary check-ups can help identify mammary tumors at an early stage, making a significant difference in the cat's outcome.

Mammary cancer can be classified into different types, including benign and malignant tumors. Understanding the type of tumor is essential for determining the best course of treatment.

If this caught your attention, see: Mammary Tumor in Dog

Mammary tumors in cats are often malignant, affecting around 80-90% of cases. This is in contrast to dogs, where only about 50% of mammary tumors are malignant.

Related reading: Mammary Gland Tumor

Cats exposed to ovarian hormones are at a higher risk of developing mammary tumors. This is why spaying is often recommended.

Spaying a cat before 6 months of age can significantly reduce the risk of mammary tumor development, with a 91% decrease in risk. This is a crucial fact for cat owners to consider.

The protective effect of spaying decreases as cats age, with spaying having no benefit after age 2 years. This means that spaying a cat too late in life may not provide the desired protection.

Administration of exogenous progestins can also lead to mammary tumor development in both male and female cats. This is another important factor for cat owners to be aware of.

Mammary cancer in cats often affects middle-aged to older cats, with a peak prevalence among 9- to 13-year-old cats. The mean age of cats at first detection of mammary adenocarcinoma is 12.3 years, with a standard deviation of 3.3 years.

Most cats with mammary cancer are spayed females, with 76% of the cats in one study being spayed females. The mean and median age at the time of ovariohysterectomy was 2.3 years and 1 year, respectively.

Mammary tumors can be solitary or multiple, with 49% of cases being solitary and 35% being multiple. The mean diameter of submitted tumors was 2.3 cm, with 8 out of 29 tumors being well-circumscribed and 3 out of 12 tumors being infiltrative.

The age of cats with mammary adenocarcinoma is a significant factor, with a mean age of 12.3 years at first detection. This age range is most prevalent among cats between 9 and 13 years old.

Domestic shorthair cats are the most common breed affected, making up 59% of the cases studied. Other breeds, such as Siamese and mixed-breed cats, are also affected, but to a lesser extent.

Mammary adenocarcinomas are often solitary, but in 35% of cases, they are multiple, meaning they appear simultaneously with two or more lumps. The mean diameter of these tumors is 2.3 cm, with some being as small as 1 cm or as large as 3 cm.

The tumors are typically firm and variably sized, ranging from small mobile nodules to larger, fixed, and ulcerated masses. The local lymph nodes, usually the axillary and inguinal lymph nodes, may be enlarged due to metastasis.

A staging system, adapted from the World Health Organization, is used to classify the disease based on tumor size, lymph node involvement, and distant metastasis. The stages are as follows:

This staging system is crucial in determining the prognosis and treatment plan for cats with mammary adenocarcinoma.

Mammary tumors can be quite distinctive in their appearance. They frequently adhere to the overlying skin but not the abdominal wall.

Ulceration is a common feature of these tumors. This can be a concern as it may lead to infection or other complications.

The nipples can appear red and swollen, and may excrete a tan to yellow fluid. This can be a noticeable symptom.

Multiple glands can be affected in over 50% of cases. This means that the tumor may not be limited to a single gland.

Lung and pleural metastasis can be extensive, causing respiratory insufficiency due to pleural carcinomatosis and effusion.

Histologic Features play a crucial role in determining the prognosis and treatment of feline mammary tumors.

The degree of nuclear differentiation is a key factor, with well-differentiated tumors being rare but associated with increased survival time.

Well-differentiated tumors have a 13% prevalence and a 100% 12-month survival rate, making them a more favorable outcome.

Moderately differentiated tumors have a 60% prevalence and a 42% 12-month survival rate, while poorly differentiated tumors have a 27% prevalence and a 0% 12-month survival rate.

The mitotic index is also an important factor, with tumors having a low mitotic index having a significantly better median survival time than those with a high mitotic index (22.4 months vs 12.4 months).

Here's a summary of the histologic features and their corresponding prevalence and survival rates:

Local invasion of the tumor significantly affects the median survival time, with tumors having local invasion only having a median survival time of 21.8 months compared to 13.4 months for tumors with blood vessel or lymphatic invasion.

Worth a look: How Do Cats Know What Time It Is?

Diagnosis of mammary cancer in cats typically starts with a cytological evaluation, which can provide a tentative diagnosis, although histological evaluation is required for a definitive diagnosis.

Fine-needle aspirates for cytological testing are a good option because they're cheaper and less invasive than a biopsy, and can often be collected without sedation.

Cytology can confirm the cell line and determine if a mass is neoplastic, but it may not be enough to determine if the neoplastic lesion is benign or malignant.

Most feline mammary tumors are malignant, so determining if the mass is malignant preoperatively is generally less important.

Intact cats can also have mammary enlargement or masses secondary to mammary hyperplasia, which typically resolves with ovariohysterectomy.

Once histological results are available, feline mammary carcinomas can be graded using the Elston and Ellis grading system, which is based on tissue differentiation, nuclear pleomorphism, and mitotic count.

Staging of Cancer is a crucial step in understanding the extent of the disease. It helps determine the best course of treatment and prognosis.

Most cats with mammary tumors are elderly and may have concurrent disease, so staging should include hematologic and biochemical testing, as well as urinalysis.

Imaging is a vital part of staging, especially for cancer that can metastasize to distant sites. It should include both thoracic and abdominal imaging, typically thoracic radiography or CT and abdominal ultrasonography.

The local/sentinel lymph nodes and lungs are the most common sites for metastasis, so imaging should focus on these areas.

You might like: Why Are My Cats so Staticy?

The prognosis for cats with mammary cancer is generally guarded, especially when considering factors like tumor size and lymph node metastasis. Cats with smaller tumors have a better chance of survival, with median survival times exceeding 3 years for those with tumors less than 2 cm.

Tumor size is a significant factor in determining prognosis, with cats having tumors larger than 3 cm facing a poorer outlook. In fact, one study found that cats with tumors larger than 3 cm had a median survival time of just 12 months. On the other hand, cats with smaller tumors can live for several years, with some studies showing median survival times of up to 3 years.

Lymph node metastasis is another key factor that affects prognosis, with cats that have metastasis at the time of surgery facing a very poor prognosis. In fact, one study found that all cats with lymph node metastasis developed progressive disease within 8 months. However, surgical approaches like bilateral mastectomy can have a positive impact on prognosis, even in cases where local lymph nodes are metastatic.

Here's a summary of the key factors that affect prognosis for cats with mammary cancer:

It's worth noting that the location of metastasis can also affect prognosis, with cats that have nodal, pulmonary, and pleural metastasis facing a progressively worse outlook.

Intact queens have a significantly higher risk of mammary cancer than spayed female cats, with a 7-fold higher risk.

Spaying your cat, regardless of age, can reduce the risk of developing mammary tumors by 40-60% compared to intact queens.

Exogenous progestins or combination of estrogen-progestin can increase the risk of developing mammary tumors, including both benign and malignant ones, by 3-fold.

Benign fibroepithelial hyperplasia may also be caused by administration of sex steroids, which can lead to unwanted side effects.

Estrogen receptors are rare in cats, but progesterone receptors are common in benign tumors, indicating a possible link between hormonal influences and tumor development.

Malignant tumors, on the other hand, tend to lose steroid dependence during malignant progression and have less frequent expression of estrogen and progesterone receptors.

Here's a summary of the risks associated with hormonal influences on mammary tumor development:

Surgery is the treatment of choice for cats with mammary tumors, allowing for tissue collection and a definitive diagnosis. It's a crucial step in treating this condition.

Multiple surgical approaches exist, but full-chain mastectomy is associated with a longer disease-free interval compared to regional mastectomy. This is a significant factor to consider when deciding on the best course of treatment.

Chemotherapy is often used in conjunction with surgery, but its effectiveness is still being debated. Some studies have shown no increased survival rates with adjuvant chemotherapy, while others suggest it may be beneficial in certain cases.

The use of doxorubicin, a common chemotherapy drug, has been evaluated in several studies. One study found that 64% of cats experienced short-term partial response with doxorubicin alone, with a median survival time (MST) of 6 months for non-responders and 8 months for responders.

Combination therapy, such as doxorubicin and cyclophosphamide, has also been studied. In one study, 50% of cats experienced short-term partial response with this combination, with an MST of 2.5 months for non-responders and 5 months for responders.

Recommended read: How Many Kittens Can a Cat Have at One Time?

Targeted therapies, such as tyrosine kinase inhibitors (TKIs), have also shown promise in treating feline mammary carcinoma. Toceranib, a TKI with antiangiogenic effects, has been shown to be well-tolerated and may be a valid option for cats with advanced mammary carcinoma.

Here's a summary of the chemotherapy regimens mentioned:

The prognosis for cats with mammary tumors is generally guarded to poor. Cats with tumors larger than 3 cm have a median survival time of only 6 months. Survival rates correlate inversely with tumor diameter.

Tumor size is a significant prognostic factor, with cats harboring tumors less than 2 cm having median survival times exceeding 3 years. However, this can vary widely, with some cats with smaller tumors living only 3-6 months.

Lymph node metastasis is a major adverse prognostic factor, with cats that have it at the time of surgery typically developing progressive disease within 8 months. Cats with stage IV disease, which includes distant metastasis, have a notably short median survival time of 44 days.

The location of metastasis also influences prognosis, with cats having nodal, pulmonary, and pleural metastasis having progressively worse median survival times. Cats with grade III mammary carcinomas, which have high tumor grade, have a significantly shorter median survival time of only 6 months.

Here is a summary of the poor prognostic factors:

Feline mammary tumours can be broadly classified into two main types: carcinomas and sarcomas. Carcinomas are the most common type, typically found in the glands of the mammary tissue and are often aggressive.

Carcinomas are further divided into different subtypes, but the exact classification is not specified in the article. Sarcomas, on the other hand, are less frequent but also aggressive and tend to spread quickly to other parts of the body.

Here's a breakdown of the types of cancer mentioned:

The primary goal of therapy for mammary cancer in cats is to remove the tumor and prevent its spread.

Surgery is the most common treatment for mammary cancer in cats, and it's often the only treatment needed for early-stage tumors.

Cats with more advanced tumors may require a combination of surgery and chemotherapy.

The American College of Veterinary Surgeons recommends that cats with mammary cancer undergo a thorough examination and diagnostic testing before surgery.

Cats with a history of mammary cancer in their family may be more likely to develop the disease themselves.

The feline mammary cancer model, also known as the MCF-7 model, is a widely used research model for studying the disease.

This model is derived from a cell line of mammary cancer cells that was first isolated in the 1970s.

Researchers have used the MCF-7 model to study the biology of mammary cancer and to test new treatments.

The MCF-7 model has helped scientists to better understand the genetic and molecular changes that occur in mammary cancer cells.